Nemes Judit, Jenei Ágnes, Márton Ildikó
Gyermekfogászati és Fogszabályozási Tanszék, Debreceni Egyetem, Klinikai Központ, Fogorvostudományi Kar Debrecen, Nagyerdei krt. 98., 4032.
Konzerváló Fogászati Tanszék, Debreceni Egyetem, Klinikai Központ, Fogorvostudományi Kar Debrecen.
Orv Hetil. 2018 Apr;159(13):495-502. doi: 10.1556/650.2018.31011.
Mucositis is the most common oral complication of cancer therapy. Oral mucositis in childhood is more frequent and severe compared to adults, especially in children with leukemia. Lesions develop as the chemotherapeutic agents attack the rapidly dividing cells of the oral mucous membrane. Patients may experience trouble in eating, drinking, swallowing or even speaking due to the significant pain caused by the ulceration of the oral mucosa. Oral mucositis has a direct impact on the quality of life and may affect survival. The regular assessment of the oral mucosa is crucial during chemotherapy to evaluate the effectiveness of the oral mucositis prevention and treatment. Several oral mucositis scoring tools have been developed for adults to qualify the symptoms, but there is no universally accepted assessment scale for children. The prevention and treatment of therapy-related mucositis is difficult, though several methods and pharmacologic agents have been tested. Here we discuss the pathogenesis of chemotherapy-induced oral mucositis, the available assessment tools and their applicability to pediatric patients and the available therapeutic and preventive strategies. Orv Hetil. 2018; 159(13): 495-502.
口腔黏膜炎是癌症治疗最常见的口腔并发症。与成人相比,儿童口腔黏膜炎更为频发且严重,尤其是白血病患儿。化疗药物攻击口腔黏膜快速分裂的细胞时会形成病变。由于口腔黏膜溃疡引发剧痛,患者在进食、饮水、吞咽甚至说话时都可能遇到困难。口腔黏膜炎直接影响生活质量,可能影响生存。化疗期间定期评估口腔黏膜对于评价口腔黏膜炎防治效果至关重要。已经开发了几种用于成人的口腔黏膜炎评分工具来确定症状,但尚无普遍接受的儿童评估量表。尽管已经测试了几种方法和药物,但治疗相关黏膜炎的防治仍很困难。在此,我们讨论化疗诱导口腔黏膜炎的发病机制、可用的评估工具及其对儿科患者的适用性以及可用的治疗和预防策略。《匈牙利医学周报》。2018年;159(13):495 - 502。